Eleni A Papadopoulos

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Venous Thromboembolism

Candida Albicans

Top Venues

Birth defects research

Pharmacoepidemiology and drug safety

The American journal on addictions

This page only lists publications with an associated author ORCID identifier.

Publications

Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997-2011. Birth defects research 116 (2) (2024)
Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997-2011. Birth defects research 116 (2) (2024)
Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997-2011. Birth defects research 116 (2) (2024)
Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997-2011. Pharmacoepidemiology and drug safety 33 (1) (2023)
Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997-2011. Pharmacoepidemiology and drug safety 33 (1) (2023)
Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997-2011. Pharmacoepidemiology and drug safety (2023)
Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997-2011. Pharmacoepidemiology and drug safety 33 (1) (2023)
Eleni A Papadopoulos, Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Martha M Werler, Paul A Romitti, Marilyn L Browne, null null
Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997-2011. Pharmacoepidemiology and drug safety 33 (1) (2023)
Meredith M Howley, Sarah C Fisher, Alissa R Van Zutphen, Eleni A Papadopoulos, Jenil R Patel, Angela E Lin, Marilyn L Browne, null null
Maternal exposure to heparin products and risk of birth defects in the National Birth Defects Prevention Study. Birth defects research (2022)
Kristin Palmsten, Jonathan Suhl, Kristin M Conway, Elyse O Kharbanda, Thomas D Scholz, Elizabeth C Ailes, Janet D Cragan, Eirini Nestoridi, Eleni A Papadopoulos, Stephen M Kerr, Sean G Young, Christine Olson, Paul A Romitti, null null
Influenza vaccination during pregnancy and risk of selected major structural congenital heart defects, National Birth Defects Prevention Study 2006-2011. Birth defects research (2022)
Eleni A Papadopoulos, Sarah C Fisher, Meredith M Howley, Marilyn L Browne, null null
Maternal hereditary hemolytic anemia and birth defects in the National Birth Defects Prevention Study. Birth defects research 114 (8) (2022)
Eleni A Papadopoulos, Karen R Cummings, Jeanna M Marraffa, Kenneth M Aldous, Lingyun Li, Nina Ahmad
Reports of adverse health effects related to synthetic cannabinoid use in New York State. The American journal on addictions 26 (8) (2017)